DM Medical Oncology – Tata Memorial Hospital, Mumbai MD Radiation Oncology, ECMO, PDCR
Designation: Consultant Medical Oncologist and Hemato-Oncologist
Vizag Experience: 6 Years
About Doctor:
English
Telugu
Hindi
Chemotherapy for Solid tumors
Breast cancer, lung cancer, CNS tumors
Head and neck cancers
Gastrointestinal cancers
Genito-urinary cancers
Gynecologic cancers
Bone cancer and Soft tissue sarcoma
Paediatric tumors
Hemato-lymphoid malignancies
Acute and chronic Leukemias
Lymphomas
Multiple Myeloma
Bone marrow transplantation
Immunotherapy
Targeted therapy (Precision Oncology)
Hormonal therapy for Breast and prostate cancer
Procedures
PICC line insertion
Bone marrow aspiration and biopsy
Lumbar puncture and intrathecal therapy
Preventive oncology and hereditary cancers
Cancer screening
Genetic counselling
Familial cancer treatment
Palliative and supportive care for advanced cancer
February 2021 to July 2021 – Worked as Assistant professor (adhoc), Dept of Medical Oncology, MPMMCC & HBCH, Varanasi.
August 2020 to January 2021 – Worked as Assistant professor (adhoc), Dept of Medical Oncology, HBCHRC, Visakhapatnam.
August 2017 to July 2020 – Senior Residency in Medical Oncology at Tata Memorial Hospital, Mumbai.
March 2017 to July 2017 – Consultant Radiation Oncologist at Surya Global Hospital, Kakinada.
May 2015 to January 2017 – Senior Resident in Dept of Radiation Oncology at KGH, Visakhapatnam.
2012 to 2015 – Resident in Dept of Radiation Oncology, GSL Medical College, Rajahmundry.
Cleared European Society of Medical Oncology (ESMO) examination in 2016, Chennai, India.
2nd prize in Hematology quiz organized by Mumbai Hematology group, 2020.
Completed Professional Diploma in Clinical Research (PDCR) examination in January 2021.
All India9th rank in DM entrance exam (Medical Oncology), NEET (2017).
Secured 99th rank in Engineering and Medical Common Entrance Test (EAMCET) in Andhra Pradesh (2005).
Daratumumab and its efficacy in refractory myeloma with anemia.Cancer Res Stat Treat 2020; 3:832-5. DOI: 10.4103/crst.crst_283_20.
Pulmonary sarcomatoid carcinoma: Retrospective analysis from a single center. e21188 poster in JCO; https://ascopubs.org/doi/abs/10.1200/JCO.2021.39.15_suppl.e21188.
Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice. Published: July 22, 2021. https://doi.org/10.1371/journal.pone.0253722
Real world data of treatment free remission in patients with chronic myeloid leukemia (CML) treated at tertiary care oncology Centre from India. 06/12/20; 297883; PB1967
European Society of Clinical Oncology (ESMO)
American Society of Clinical Oncology (ASCO)
Indian Cooperative Oncology Network (ICON)
Association of Radiation Oncologists of India (AROI)